Comprehensive Identification of Post-translational Modifications of Rat Bone Osteopontin by Mass Spectrometry
- 13 April 2005
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 44 (18) , 6990-7003
- https://doi.org/10.1021/bi050109p
Abstract
Osteopontin (OPN) is a highly modified protein that is found in many tissues and has been associated with a variety of physiological and pathological processes. Bone OPN is a potent inhibitor of hydroxyapatite crystal formation and stimulates bone resorption by osteoclasts; these activities, as well as others, are dependent upon phosphorylation of the protein. We have used mass spectrometry (MS) to perform a comprehensive analysis of the post-translational modification of OPN purified from rat bone. Matrix-assisted laser desorption time-of-flight (MALDI−TOF) MS showed masses of 37.6 and 36.8 kDa before and after enzymatic dephosphorylation, respectively, corresponding to a content of approximately 10.4 phosphate groups. Using proteolytic digestion and tandem MS, we localized 29 sites of phosphorylation: S10, S11, S46, S47, T50, S60, S62, S65, S146, T154, S160, S164, S167, S193, S196, S203, S220, S223, S232, S241, S245, S257, S262, S267, S278, S290, S295, S296, and S297. In addition, Y150 was shown to be sulfated and T107, T110, T116, and T121 are O-glycosylated. No glycan was detected at the potential N-glycosylation site. Other modifications, including deamidation, oxidation, and carbamylation, are also present. A 36-amino acid sequence from residues 67−102 could not be analyzed in detail, even after sialidase treatment, presumably because of the presence of a large number of acidic residues. In comparison to the previously characterized cow milk isoform, rat bone OPN is sulfated and has an additional site of glycosylation, many different sites of phosphorylation, and a lower overall phosphate content.Keywords
This publication has 24 references indexed in Scilit:
- Inhibition of hydroxyapatite formation by osteopontin phosphopeptidesBiochemical Journal, 2004
- One‐thousand‐and‐one substrates of protein kinase CK2?The FASEB Journal, 2003
- Phosphorylated osteopontin peptides suppress crystallization by inhibiting the growth of calcium oxalate crystalsKidney International, 2001
- Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survivalJournal of Clinical Investigation, 2001
- Osteopontin: a key cytokine in cell‐mediated and granulomatous inflammationInternational Journal of Experimental Pathology, 2000
- Phosphorylation of Osteopontin Is Required for Inhibition of Vascular Smooth Muscle Cell CalcificationJournal of Biological Chemistry, 2000
- Osteopontin Expression by Osteoclast and Osteoblast Progenitors in the Murine Bone Marrow: Demonstration of Its Requirement for Osteoclastogenesis and Its Increase After Ovariectomy*Endocrinology, 1997
- Purification of mineralized tissue-associated osteopontinJournal of Tissue Culture Methods, 1994
- Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques.Journal of Clinical Investigation, 1993
- The calcium oxalate crystal growth inhibitor protein produced by mouse kidney cortical cells in culture is osteopontinJournal of Bone and Mineral Research, 1992